Abstract:OBJECTIVE:To evaluate the possibility and efficiency of nanoparticle as a new vector in vascular endothelial growth factor (VEGF) gene transference, and investigate the efficacy of direct gene transfer of nanoparticle with VEGF(165) gene into ischemic myocardium.METHODS:Nanoparticle-VEGF (Np/VEGF) complex was prepared with poly (D, L-lactide-co-glycolide) (PLGA) loading VEGF(165) gene and the envelopment efficiency and size of the complex were determined. The Np/VEGF was transfected into the cultured myocardial cells, RT-PCR and ELISA were used to evaluate the transfection of VEGF. Suspension of Np/VEGF was injected into the myocardial tissue of 4 rabbits. 96 hours after operation myocardial tissue was obtained, made into sections, and observed with electron microscope. New Zealand White rabbits underwent thoracotomy followed by ligation of left anterior descending coronary artery to establish ischemic models. The New Zealand White rabbits were divided into 3 groups: Np/VEGF group (n = 12, nanoparticle with VEGF(165) were injected into the cordial myocardium), blank plasmid group (n = 12, injected with blank VEGF(165) plasmid), and control group (n = 8, injected with normal saline). Ultrasonography and immunohistochemistry with factor VIII related antigen were conducted to evaluate the cardiac function and the collateral circulation of the occluded artery. One month later the rabbits were killed to observe the vascularization of capillaries in the ischemic myocardium.RESULTS:The envelopment efficiency of the Np/VEGF complex thus prepared, 50 - 300 nm in size, were 1.87% y. RT-PCR and ELISA showed that VEGF gene had been successfully transfected into myocardial cells by the nanoparticles. A great number of nanoparticles were observed in the myocardial cytoplasm and nuclei. One month after operation, the ventricular wall motor amplitude of the Np/VEGF group was 1.87 mm +/- 0.32 mm, significantly larger than those of the blank plasmid group (1.59 mm +/- 0.24 mm, P < 0.05) and control group (0.93 mm +/- 0.40 mm, P < 0.05); and the left ventricular ejection fraction of the Np/VEGF group was 60% +/- 10%, significantly higher than those of the blank plasmid group (50% +/- 6%, P < 0.05) and control group (40% +/- 8%, P < 0.05). The capillary density at low power field (x 100) of the Np/VEGF group was 57 +/- 12, significantly higher than those of the VEGF group (41 +/- 14) and control group (24 +/- 8).CONCLUSION:Nanoparticle can act as a vector to transfect specific gene in vitro and in vivo. Direct gene transfer of nanoparticle with DNA encoding VEGF into the ischemic rabbit myocardium can increase capillary number; therefore it may be a novel therapeutic approach for myocardial ischemia.

Gene Transfer of Vascular Endothelial Growth Factor Reduces Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits.

[Effect of VEGF Gene Transfer on the Bleomycin-Induced Pulmonary Hypertension in Immature Rabbits].

VEGFmRNA and Enosmrna Expression in Immature Rabbits with Bleomycin-Induced Pulmonary Hypertension.

Pathophysiology of bleomycin-induced pulmonary hypertension in immature rabbits]

Enhancement of the Anti-Apoptotic and Angiogenic Properties of Bone Marrow-Derived Endothelial Progenitor Cells by Bcl-2 Gene Transfer in Rats

In Vivo Transfection of Hepatocyte Growth Factor Gene Induces Pulmonary Angiogenesis in Rabbits with Hyperkinetic Pulmonary Hypertension

Recombinant human hepatocyte growth factor transfection alleviates hyperkinetic pulmonary artery hypertension in rabbit models

Effect of Exogenous HGF Gene Transfection on Pulmonary Perfusion and Pressure in Pulmonary Artery Hypertension in Rabbits

[Effects of Sense Vascular Endothelial Growth Factor Cdna Transfection on Mononuclear Chemotaxis Protein-1 Expression in Rat Pulmonary Microvessel Endothelial Cells].

Ultrasound-mediated HGF Gene Microbubbles Mitigate Hyperkinetic Pulmonary Arterial Hypertension in Rabbits

Enos Gene Transfection on Pulmonary Artery Hypertension and Hypertension Crisis in Rabbits

Gene transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits.

Transfection of Human Hepatocyte Growth Factor Gene Inhibits Advancing Pulmonary Arterial Hypertension Induced by Shunt Flow in a Rabbit Model.

[Effect of Nanoparticle with Vascular Endothelial Growth Factor Gene Transferred into Ischemic Myocardium: Experiment with Rabbits].

Inhibitory effects of local transfection of vascular endothelial growth factor 165 gene on intimal hyperplasia of artery in rabbits after operation injury

[Relationship Between Bleomycin-Induced Pulmonary Fibrosis and Vascular Endothelial Cell Injury].

Nanoparticle delivery of VEGF and SDF‐1α as an approach for treatment of pulmonary arterial hypertension

VEGFR-2 Antagonist SU5416 Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

Effects of pyrin recombinant protein on VEGF/VEGFR2/MMP-9 signaling pathway in pulmonary fibrosis of rats

Gene Transfer of Hepatocyte Growth Factor by Electroporation Reduces Bleomycin-Induced Lung Fibrosis

[Effect of platelet-derived growth factor-BB on pulmonary vascular remodeling in neonatal rats with hypoxic pulmonary hypertension and its mechanism]